146 related articles for article (PubMed ID: 9407567)
1. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
[TBL] [Abstract][Full Text] [Related]
2. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
Billman D; Nicks J; Schumacher R
Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
4. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
5. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
[TBL] [Abstract][Full Text] [Related]
7. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
[TBL] [Abstract][Full Text] [Related]
8. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
10. [Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
Mikhel'sonVA ; Grebennikov VA; Belaĭ VA; Everstova TN
Anesteziol Reanimatol; 1995; (1):4-7. PubMed ID: 7605034
[TBL] [Abstract][Full Text] [Related]
11. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
Lloyd J; Todd DA; John E
Early Hum Dev; 1999 Mar; 54(2):157-68. PubMed ID: 10213294
[TBL] [Abstract][Full Text] [Related]
12. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
[TBL] [Abstract][Full Text] [Related]
14. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
[TBL] [Abstract][Full Text] [Related]
15. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
Bhutani VK; Bowen FW; Sivieri EM
Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
[TBL] [Abstract][Full Text] [Related]
16. Lung function in prematurely delivered rabbits treated with a synthetic surfactant.
Tooley WH; Clements JA; Muramatsu K; Brown CL; Schlueter MA
Am Rev Respir Dis; 1987 Sep; 136(3):651-6. PubMed ID: 3307569
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
Hamdan AH; Shaw NJ
Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
[TBL] [Abstract][Full Text] [Related]
18. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Abbasi S; Bhutani VK; Gerdes JS
J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
[TBL] [Abstract][Full Text] [Related]
19. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
20. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
Rubin BK; Ramirez O; King M
Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]